Mahdi Shabani Selected Research

Mahdi Shabani Research Topics

Disease

23	Neoplasms (Cancer) 10/2023 - 07/2006
7	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 01/2007
5	Breast Neoplasms (Breast Cancer) 10/2023 - 01/2016
5	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2017 - 07/2008
3	COVID-19 07/2022 - 01/2021
3	Ovarian Neoplasms (Ovarian Cancer) 12/2018 - 04/2013
3	Leukemia 07/2011 - 07/2006
2	Residual Neoplasm 01/2007 - 07/2006
1	Neoplasm Metastasis (Metastasis) 10/2023
1	Testicular Neoplasms (Testicular Cancer) 07/2023
1	Cross Infection (Nosocomial Infection) 06/2022
1	Bacillary Dysentery (Shigellosis) 02/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Infections 12/2021
1	Behcet Syndrome (Behcet's Syndrome) 01/2019
1	Lung Neoplasms (Lung Cancer) 03/2018
1	Communicable Diseases (Infectious Diseases) 01/2018
1	Brucellosis (Malta Fever) 04/2015
1	Prostatic Neoplasms (Prostate Cancer) 01/2015
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2011
1	Myeloid Leukemia (Leukemia, Myelocytic) 07/2011
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 06/2009
1	Pathologic Processes 01/2007

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 09/2022 - 07/2006
7	AntigensIBA 07/2023 - 07/2006
4	Monoclonal AntibodiesIBA 08/2023 - 01/2016
4	AntibodiesIBA 12/2022 - 01/2021
4	Caspase 3 (Caspase-3)IBA 12/2021 - 04/2013
4	Messenger RNA (mRNA)IBA 08/2015 - 02/2008
3	Anti-Bacterial Agents (Antibiotics)IBA 06/2022 - 12/2021
3	Small Interfering RNA (siRNA)IBA 03/2018 - 07/2015
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 07/2011 - 01/2007
2	MicroRNAs (MicroRNA)IBA 10/2023 - 01/2019
2	ChitosanIBA 10/2023 - 03/2018
2	human ERBB2 proteinIBA 08/2023 - 01/2016
2	Immunoglobulin G (IgG)IBA 07/2022 - 12/2021
2	Immunoglobulin M (IgM)IBA 07/2022 - 12/2021
2	Peptides (Polypeptides)IBA 01/2022 - 07/2015
2	Immunoglobulins (Immunoglobulin)IBA 12/2021 - 01/2020
2	Tyrosine Kinase InhibitorsIBA 04/2017 - 07/2015
2	Receptor Tyrosine Kinase-like Orphan ReceptorsIBA 04/2017 - 07/2015
2	Phosphotransferases (Kinase)IBA 01/2016 - 01/2007
2	tyrosine receptor (receptor, tyrosine)IBA 01/2016 - 01/2007
2	Fc Receptors (Fc Receptor)IBA 06/2009 - 11/2008
1	Immune Checkpoint InhibitorsIBA 04/2023
1	Sodium Dodecyl Sulfate (Sodium Lauryl Sulfate)IBA 01/2023
1	ProteomeIBA 01/2023
1	cabozantinibIBA 12/2022
1	antineoplaston A10 (A 10)IBA 12/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2022
1	methylselenic acidIBA 09/2022
1	AntioxidantsIBA 09/2022
1	Leucovorin (Folinic Acid)FDA Link 09/2022
1	Methotrexate (Mexate)FDA LinkGeneric 09/2022
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 09/2022
1	alpha-Tocopherol FDA Link 09/2022
1	Selenic AcidIBA 09/2022
1	Interferon-gamma (Interferon, gamma)IBA 04/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	GoldIBA 01/2022
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	Mucin-3IBA 12/2021
1	Galectins (Galectin)IBA 12/2021
1	MucinsIBA 01/2020
1	CytokinesIBA 01/2019
1	LectinsIBA 12/2018
1	Caspase 6IBA 12/2018
1	Insulin-Like PeptidesIBA 03/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2018
1	Protein Kinases (Protein Kinase)IBA 04/2017
1	Adenosine-5'-(N-ethylcarboxamide) (NECA)IBA 08/2015
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 08/2015
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2015
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	Adenosine (Adenocard)FDA LinkGeneric 04/2013
1	CaspasesIBA 04/2013
1	EnzymesIBA 01/2007

Therapy/Procedure

10	Immunotherapy 12/2022 - 07/2006
5	Therapeutics 09/2022 - 07/2015
2	Cell- and Tissue-Based Therapy (Cell Therapy) 04/2017 - 07/2015
1	Aftercare (After-Treatment) 10/2023
1	Radiotherapy 04/2023
1	Precision Medicine 01/2016